| Authors: |
Burrows GG; Center for Hematologic Malignancies, Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon, USA ggb@ohsu.edu., Van't Hof W; Regenerative Medicine Program, Athersys Inc., Cleveland, Ohio, USA National Center for Regenerative Medicine, Cleveland, Ohio, USA., Reddy AP; Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon, USA., Wilmarth PA; Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon, USA., David LL; Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon, USA., Raber A; Regenerative Medicine Program, Athersys Inc., Cleveland, Ohio, USA., Bogaerts A; ReGenesys, Inc., Leuven, Belgium., Timmerman L; ReGenesys, Inc., Leuven, Belgium., Pinxteren J; ReGenesys, Inc., Leuven, Belgium., Roobrouck VD; ReGenesys, Inc., Leuven, Belgium., Deans RJ; Regenerative Medicine Program, Athersys Inc., Cleveland, Ohio, USA National Center for Regenerative Medicine, Cleveland, Ohio, USA ReGenesys, Inc., Leuven, Belgium., Maziarz RT; Center for Hematologic Malignancies, Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA. |
